$PRSO
Peraso Inc.

2023 Q3 Form 10-Q Financial Statement

#000121390023067163 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $4.481M $2.403M
YoY Change 36.04% -43.91%
Cost Of Revenue $2.445M $1.795M
YoY Change 22.25% -35.87%
Gross Profit $2.036M $608.0K
YoY Change 57.34% -59.06%
Gross Profit Margin 45.44% 25.3%
Selling, General & Admin $2.112M $1.977M
YoY Change -37.01% -31.31%
% of Gross Profit 103.73% 325.16%
Research & Development $3.484M $3.668M
YoY Change -22.73% -35.0%
% of Gross Profit 171.12% 603.29%
Depreciation & Amortization $1.050M $958.0K
YoY Change 40.19% 25.39%
% of Gross Profit 51.57% 157.57%
Operating Expenses $5.596M $5.645M
YoY Change 5.49% -33.75%
Operating Profit -$3.560M -$5.037M
YoY Change -11.24% -28.41%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $2.940M $951.0K
YoY Change 36650.0% -95200.0%
Pretax Income -$620.0K -$4.086M
YoY Change -84.53% -41.98%
Income Tax
% Of Pretax Income
Net Earnings -$623.0K -$4.086M
YoY Change -84.46% -41.98%
Net Earnings / Revenue -13.9% -170.04%
Basic Earnings Per Share -$0.02 -$0.17
Diluted Earnings Per Share -$0.02 -$0.17
COMMON SHARES
Basic Shares Outstanding 22.44M shares 15.73M shares
Diluted Shares Outstanding 28.59M shares 24.34M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $700.0K $2.740M
YoY Change -82.16% -44.24%
Cash & Equivalents $689.0K $2.146M
Short-Term Investments $0.00 $594.0K
Other Short-Term Assets $800.0K $729.0K
YoY Change -47.3% -49.59%
Inventory $5.696M $5.160M
Prepaid Expenses
Receivables $3.064M $1.497M
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.23M $10.13M
YoY Change -23.79% -32.68%
LONG-TERM ASSETS
Property, Plant & Equipment $1.624M $1.850M
YoY Change -21.09% -9.62%
Goodwill
YoY Change
Intangibles $4.209M $5.031M
YoY Change -38.13% -31.34%
Long-Term Investments
YoY Change
Other Assets $121.0K $123.0K
YoY Change -6.2% -19.08%
Total Long-Term Assets $6.601M $7.824M
YoY Change -67.19% -64.29%
TOTAL ASSETS
Total Short-Term Assets $10.23M $10.13M
Total Long-Term Assets $6.601M $7.824M
Total Assets $16.83M $17.95M
YoY Change -49.82% -51.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.583M $1.142M
YoY Change 48.11% -52.12%
Accrued Expenses $1.000M $1.625M
YoY Change -46.44% -8.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.694M $2.942M
YoY Change -17.23% -42.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.400M $3.967M
YoY Change 152.71% 449.45%
Total Long-Term Liabilities $1.400M $3.967M
YoY Change 152.71% 449.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.694M $2.942M
Total Long-Term Liabilities $1.400M $3.967M
Total Liabilities $5.076M $6.909M
YoY Change 1.18% 17.68%
SHAREHOLDERS EQUITY
Retained Earnings -$157.5M -$156.8M
YoY Change 16.63% 19.72%
Common Stock $25.00K $22.00K
YoY Change -99.98% -99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.76M $11.04M
YoY Change
Total Liabilities & Shareholders Equity $16.83M $17.95M
YoY Change -49.82% -51.42%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$623.0K -$4.086M
YoY Change -84.46% -41.98%
Depreciation, Depletion And Amortization $1.050M $958.0K
YoY Change 40.19% 25.39%
Cash From Operating Activities -$2.060M -$2.160M
YoY Change 10.93% -62.9%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $7.000K
YoY Change -100.0% -102.62%
Acquisitions
YoY Change
Other Investing Activities $600.0K $0.00
YoY Change -71.43% -100.0%
Cash From Investing Activities $600.0K -$7.000K
YoY Change -67.83% -100.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 3.508M
YoY Change -100.0% -4715.79%
NET CHANGE
Cash From Operating Activities -2.060M -2.160M
Cash From Investing Activities 600.0K -7.000K
Cash From Financing Activities 0.000 3.508M
Net Change In Cash -1.460M 1.341M
YoY Change -4662.5% -238.11%
FREE CASH FLOW
Cash From Operating Activities -$2.060M -$2.160M
Capital Expenditures $0.00 $7.000K
Free Cash Flow -$2.060M -$2.167M
YoY Change 27.0% -60.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21636000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-32929
dei Entity Registrant Name
EntityRegistrantName
PERASO INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0291941
dei Entity Address Address Line1
EntityAddressAddressLine1
2309 Bering Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95131
dei City Area Code
CityAreaCode
(408)
dei Local Phone Number
LocalPhoneNumber
418-7500
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
PRSO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22439012 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2146000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1828000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
594000 usd
CY2023Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
729000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
615000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
1078000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1497000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3244000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
5160000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
5348000 usd
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
600000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
10126000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
12713000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1850000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2225000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5031000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6278000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
820000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1147000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
123000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
123000 usd
CY2023Q2 us-gaap Assets
Assets
17950000 usd
CY2022Q4 us-gaap Assets
Assets
22486000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1142000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1844000 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1161000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1817000 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
175000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
332000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
464000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
687000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2942000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4680000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
349000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
470000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
3618000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2079000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
6909000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
7229000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22170000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22170000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14270000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14270000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
22000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
14000 usd
CY2023Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
5731000 shares
CY2022Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
9107000 shares
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
167854000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
164865000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-156831000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-149597000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
11041000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15257000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17950000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22486000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2403000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4284000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7436000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7687000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
1795000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
2799000 usd
us-gaap Cost Of Revenue
CostOfRevenue
4901000 usd
us-gaap Cost Of Revenue
CostOfRevenue
4747000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
608000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
1485000 usd
us-gaap Gross Profit
GrossProfit
2535000 usd
us-gaap Gross Profit
GrossProfit
2940000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3668000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5643000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7555000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11127000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1977000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2878000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4219000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5585000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
406000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
5645000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
8521000 usd
us-gaap Operating Expenses
OperatingExpenses
11368000 usd
us-gaap Operating Expenses
OperatingExpenses
16712000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5037000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7036000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8833000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13772000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-966000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1624000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-15000 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-7000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-25000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-25000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4086000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7043000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7234000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13797000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Cash Flow Hedging Instruments
UnrealizedGainLossOnCashFlowHedgingInstruments
7000 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Cash Flow Hedging Instruments
UnrealizedGainLossOnCashFlowHedgingInstruments
-4000 usd
us-gaap Unrealized Gain Loss On Cash Flow Hedging Instruments
UnrealizedGainLossOnCashFlowHedgingInstruments
21000 usd
us-gaap Unrealized Gain Loss On Cash Flow Hedging Instruments
UnrealizedGainLossOnCashFlowHedgingInstruments
-41000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4079000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7047000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7213000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13838000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24338000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21636000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22442000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21610000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15257000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1307000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3148000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
13430000 usd
CY2023Q2 prso Issuance Of Common Stock Under Stock Plan Net
IssuanceOfCommonStockUnderStockPlanNet
-36000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3548000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3162000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1319000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4086000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
11041000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
42069000 usd
CY2022Q1 prso Issuance Of Common Stock Under Stock Plan Net
IssuanceOfCommonStockUnderStockPlanNet
-9000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1171000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-37000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6754000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
36440000 usd
CY2022Q2 prso Issuance Of Common Stock Under Stock Plan Net
IssuanceOfCommonStockUnderStockPlanNet
-50000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1738000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7043000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
31081000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7234000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13797000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1713000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1540000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2626000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2909000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1624000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-154000 usd
prso Accrued Interest On Investments
AccruedInterestOnInvestments
-12000 usd
prso Accrued Interest On Investments
AccruedInterestOnInvestments
13000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
5000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
154000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1900000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
791000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-189000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
561000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-485000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
331000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-702000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
474000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
332000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
256000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-285000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-242000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-813000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1186000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3574000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11562000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
91000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
342000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
21000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
500000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9434000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
497000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
409000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8574000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3570000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
36000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
59000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
51000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
26000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3483000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-85000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
318000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3073000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1828000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5893000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2146000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2820000 usd
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
3162000 usd
prso Recognition Of Rightofuse Assets And Lease Liabilities
RecognitionOfRightofuseAssetsAndLeaseLiabilities
995000 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-21000 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-41000 usd
CY2021Q3 prso Agreement Amount
AgreementAmount
2864555000 shares
CY2023Q2 us-gaap Net Investment In Lease Allowance For Credit Loss
NetInvestmentInLeaseAllowanceForCreditLoss
7200000 usd
CY2022Q4 us-gaap Net Investment In Lease Allowance For Credit Loss
NetInvestmentInLeaseAllowanceForCreditLoss
32400000 usd
CY2023Q2 us-gaap Retained Earnings Unappropriated
RetainedEarningsUnappropriated
156800000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses recognized during the reported period. Material estimates may include assumptions made in determining reserves for uncollectible receivables, inventory write-downs, impairment of long-term assets, purchase price allocations, valuation allowance on deferred tax assets, accruals for potential liabilities and assumptions made in valuing equity instruments. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p>
us-gaap Inventory Write Down
InventoryWriteDown
629000000 usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
160000000 usd
CY2023Q2 prso Allowance For Doubtful Accounts As Percentage Of Invoice Value For Problematic Customer Balances Maximum
AllowanceForDoubtfulAccountsAsPercentageOfInvoiceValueForProblematicCustomerBalancesMaximum
1 pure
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
30000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
183000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8468000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-3437000 usd
CY2023Q2 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
5031000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8468000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-2190000 usd
CY2022Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
6278000 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
7000000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
14000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1645000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3289000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
28000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
28000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
10000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
31000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5031000 usd
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company sells its products both directly to customers and through distributors generally under agreements with payment terms typically 60 days or less.
CY2022 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
1100000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
157000000 usd
prso Revenue Practical Expedient Period In Which Customer Payments Due From Invoice Date
RevenuePracticalExpedientPeriodInWhichCustomerPaymentsDueFromInvoiceDate
P60D
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13720000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4789000 shares
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1474000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
5160000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
5348000 usd
CY2023Q2 prso Corporate Notes And Commercial Paper
CorporateNotesAndCommercialPaper
594000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
3618000 usd
CY2022Q4 prso Corporate Notes And Commercial Paper
CorporateNotesAndCommercialPaper
1078000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2079000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2726000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2740000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2931000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
25000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2906000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
617000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1279000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2448000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2595000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2095000 usd
CY2023Q1 us-gaap Incentive To Lessee
IncentiveToLessee
220000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1000000 usd
CY2023Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.08 pure
CY2022Q1 prso Lease Liability
LeaseLiability
274000000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
124000000 usd
CY2022Q4 prso Lease Liability
LeaseLiability
117000000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
562000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
258000 usd
CY2023Q2 prso Operating Lease Right Of Use Assets
OperatingLeaseRightOfUseAssets
820000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
554000 usd
CY2023Q2 prso Finance Lease Liabilities
FinanceLeaseLiabilities
259000 usd
CY2023Q2 prso Operating And Financing Lease Liabilities
OperatingAndFinancingLeaseLiabilities
813000 usd
CY2023Q2 prso Operating Leases Future Minimum Payment Due Current
OperatingLeasesFutureMinimumPaymentDueCurrent
283000 usd
CY2023Q2 prso Operating Leases Future Minimum Payment Due In Two Years
OperatingLeasesFutureMinimumPaymentDueInTwoYears
265000 usd
CY2023Q2 prso Operating Leases Future Minimum Payment Due In Three Years
OperatingLeasesFutureMinimumPaymentDueInThreeYears
166000 usd
CY2023Q2 prso Operating Leases Future Minimum Payment Due In Four Years
OperatingLeasesFutureMinimumPaymentDueInFourYears
110000 usd
CY2023Q2 prso Operating Leases Future Minimum Payment Due In Five Years
OperatingLeasesFutureMinimumPaymentDueInFiveYears
83000 usd
CY2023Q2 prso Operating Leases Future Minimum Payment Due
OperatingLeasesFutureMinimumPaymentDue
907000 usd
CY2023Q2 us-gaap Receivable With Imputed Interest Net Amount
ReceivableWithImputedInterestNetAmount
94000 usd
CY2023Q2 prso Present Value Of Lease Liabilities
PresentValueOfLeaseLiabilities
813000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
403000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
283000 usd
CY2023Q2 prso Rent Expense
RentExpense
200000 usd
CY2022Q2 prso Rent Expense
RentExpense
200000 usd
prso Rent Expense
RentExpense
400000 usd
prso Rent Expense
RentExpense
400000 usd
CY2023Q2 us-gaap Recorded Unconditional Purchase Obligation Amount Of Maturities And Sinking Fund Requirements
RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements
2200000 usd
CY2023Q2 us-gaap Recorded Unconditional Purchase Obligation Nonfinancial Assets Pledged As Security Value
RecordedUnconditionalPurchaseObligationNonfinancialAssetsPledgedAsSecurityValue
2900000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2403000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4284000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7436000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7687000 usd
CY2023Q2 prso Product Category
ProductCategory
2235000 usd
CY2022Q2 prso Product Category
ProductCategory
4120000 usd
prso Product Category
ProductCategory
7123000 usd
prso Product Category
ProductCategory
7324000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.10 pure
CY2023Q2 us-gaap Percentage Of Fifo Inventory
PercentageOfFIFOInventory
0.10 pure
prso Accounts Receiveble Percentage
AccountsReceiveblePercentage
0.74 pure
CY2022 prso Accounts Receiveble Percentage
AccountsReceiveblePercentage
0.79 pure
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2100000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2200000 usd
CY2023Q2 us-gaap Financing Receivable Unamortized Loan Fee Cost
FinancingReceivableUnamortizedLoanFeeCost
5600000 usd
prso Share Based Compensation Arrangement By Share Based Payment Award Term Of Plan
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfPlan
P1Y4M24D
prso Percentage Of Voting Power
PercentageOfVotingPower
0.10 pure
CY2022Q4 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.01
CY2022Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2100000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1057000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.06
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
80000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.99
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
51000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.07
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1086000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.98
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
69000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.52
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
210000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.16
CY2023Q2 prso Share Based Compensation Number Of Shares Cancels
ShareBasedCompensationNumberOfSharesCancels
-3000 shares
CY2023Q2 prso Weighted Average Grant Date Fair Value Cancels
WeightedAverageGrantDateFairValueCancels
2.15
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
942000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.84
prso Exchangeable Percentage
ExchangeablePercentage
0.10 pure
prso Voting Power Percentage
VotingPowerPercentage
0.50 pure
CY2023Q2 us-gaap Shares Issued
SharesIssued
2250000000 shares
CY2023Q2 prso Purchase Price Per Share
PurchasePricePerShare
0.7
CY2023Q2 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.01
CY2023Q2 us-gaap Shares Issued
SharesIssued
967286000 shares
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3600000 usd
CY2022Q4 us-gaap Shares Issued
SharesIssued
1300000000 shares
CY2022Q4 prso Purchase Price Per Share
PurchasePricePerShare
1
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2497000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2497000000 shares
CY2022Q4 prso Common Stock Number Of Shares
CommonStockNumberOfShares
1284000 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
33000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1 pure
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
3162401 usd
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2246365 usd
us-gaap Extended Product Warranty Description
ExtendedProductWarrantyDescription
Black Scholes model with the following assumptions: (i) expected term based on the remaining contractual terms, (ii) risk-free interest rate of 4.16%, which was based on a comparable US Treasury 5-year bond, (iii) expected volatility of 118% and (iv) an expected dividend of zero.
CY2022 prso Number Of Warrants On Common Shares Recognition Of Warrant Liability
NumberOfWarrantsOnCommonSharesRecognitionOfWarrantLiability
3675000 shares
CY2022 prso Amount Recognition Of Warrant Liability
AmountRecognitionOfWarrantLiability
3674000 usd
CY2022 prso Amount Change In Fair Value Of Warrants
AmountChangeInFairValueOfWarrants
-1595000 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3675000 shares
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2079000 usd
CY2023Q1 prso Amount Change In Fair Value Of Warrants
AmountChangeInFairValueOfWarrants
-658000 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3675000 shares
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1421000 usd
CY2023Q2 prso Number Of Warrants On Common Shares Recognition Of Warrant Liability
NumberOfWarrantsOnCommonSharesRecognitionOfWarrantLiability
5714000 shares
CY2023Q2 prso Amount Recognition Of Warrant Liability
AmountRecognitionOfWarrantLiability
3163000 usd
CY2023Q2 prso Amount Change In Fair Value Of Warrants
AmountChangeInFairValueOfWarrants
-966000 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9389000 shares
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3618000 usd
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
92200000 usd
us-gaap Asset Acquisition Consideration Transferred Transaction Cost
AssetAcquisitionConsiderationTransferredTransactionCost
3062500000 usd
us-gaap Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable
AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable
437500000 usd
CY2022 prso Gain On Transaction
GainOnTransaction
2600000 usd
prso Gain On Transaction
GainOnTransaction
400000 usd
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
usd
prso Recognition Of Rightofuse Assets And Lease Liabilities
RecognitionOfRightofuseAssetsAndLeaseLiabilities
usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
usd
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
shares
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
usd
CY2022 prso Number Of Warrants On Common Shares Change In Fair Value Of Warrants
NumberOfWarrantsOnCommonSharesChangeInFairValueOfWarrants
shares
CY2023Q1 prso Number Of Warrants On Common Shares Change In Fair Value Of Warrants
NumberOfWarrantsOnCommonSharesChangeInFairValueOfWarrants
shares
CY2023Q2 prso Number Of Warrants On Common Shares Change In Fair Value Of Warrants
NumberOfWarrantsOnCommonSharesChangeInFairValueOfWarrants
shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000890394

Files In Submission

Name View Source Status
prso-20230630_cal.xml Edgar Link unprocessable
prso-20230630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001213900-23-067163-index-headers.html Edgar Link pending
0001213900-23-067163-index.html Edgar Link pending
0001213900-23-067163.txt Edgar Link pending
0001213900-23-067163-xbrl.zip Edgar Link pending
f10q0623ex31-1_perasoinc.htm Edgar Link pending
f10q0623ex31-2_perasoinc.htm Edgar Link pending
f10q0623ex32-1_perasoinc.htm Edgar Link pending
f10q0623_perasoinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
prso-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
prso-20230630_lab.xml Edgar Link unprocessable
prso-20230630_pre.xml Edgar Link unprocessable
f10q0623_perasoinc_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending